These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6744269

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of acivicin and dipyridamole on hepatoma 3924A cells.
    Zhen YS, Lui MS, Weber G.
    Cancer Res; 1983 Apr; 43(4):1616-9. PubMed ID: 6831407
    [Abstract] [Full Text] [Related]

  • 3. Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.
    Fischer PH, Willson JK, Risueno C, Tutsch K, Bruggink J, Ranhosky A, Trump DL.
    Cancer Res; 1988 Oct 01; 48(19):5591-6. PubMed ID: 3416312
    [Abstract] [Full Text] [Related]

  • 4. Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.
    Willson JK, Fischer PH, Tutsch K, Alberti D, Simon K, Hamilton RD, Bruggink J, Koeller JM, Tormey DC, Earhart RH.
    Cancer Res; 1988 Oct 01; 48(19):5585-90. PubMed ID: 3416311
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
    Chen SF, Ruben RL, Dexter DL.
    Cancer Res; 1986 Oct 01; 46(10):5014-9. PubMed ID: 3019518
    [Abstract] [Full Text] [Related]

  • 9. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL, Fischer PH.
    Cancer Res; 1986 Dec 01; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mechanism of action of a new antitumor agent, carbetimer.
    Ardalan B, Paget GE.
    Cancer Res; 1986 Nov 01; 46(11):5473-6. PubMed ID: 3756894
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
    Kinahan JJ, Pavelic ZP, Leonard RJ, Bloch A, Grindey GB.
    Cancer Res; 1980 Mar 01; 40(3):598-603. PubMed ID: 7471080
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
    Curtin NJ, Bowman KJ, Turner RN, Huang B, Loughlin PJ, Calvert AH, Golding BT, Griffin RJ, Newell DR.
    Br J Cancer; 1999 Aug 01; 80(11):1738-46. PubMed ID: 10468290
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention of central nervous system toxicity of the antitumor antibiotic acivicin by concomitant infusion of an amino acid mixture.
    Williams MG, Earhart RH, Bailey H, McGovren JP.
    Cancer Res; 1990 Sep 01; 50(17):5475-80. PubMed ID: 2386952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.